Modular Medical Updates Principal Executive Office Address
Ticker: MODD · Form: 8-K · Filed: Jan 19, 2024 · CIK: 1074871
Complexity: simple
Sentiment: neutral
Topics: administrative, corporate-governance, address-change
TL;DR
**MODD filed an 8-K to update its corporate address, a minor administrative change.**
AI Summary
Modular Medical, Inc. (MODD) filed an 8-K on January 19, 2024, to update its principal executive offices to 10740 Thornmint Road, San Diego, California 92127. This change in address is a routine administrative update and does not indicate any significant operational or financial shifts for the company. For investors, this filing primarily serves as a record of the company's current physical location, which is important for official communications but has no direct impact on the stock's value or the company's business prospects.
Why It Matters
This filing is a routine administrative update of Modular Medical's corporate address, which is important for official records but has no direct impact on the company's operations or financial performance.
Risk Assessment
Risk Level: low — This filing is purely administrative, reporting a change of address, and carries no inherent financial or operational risk.
Analyst Insight
A smart investor would note this administrative update but understand it has no material impact on Modular Medical's (MODD) investment thesis or operational outlook, thus requiring no immediate action.
Key Players & Entities
- Modular Medical, Inc. (company) — the registrant filing the 8-K
- 10740 Thornmint Road, San Diego, California 92127 (address) — the new principal executive offices
- January 19, 2024 (date) — date of earliest event reported
- MODD (ticker) — trading symbol for Modular Medical, Inc.
- The Nasdaq Stock Market LLC (company) — exchange where Common Stock is registered
FAQ
What is the primary purpose of Modular Medical, Inc.'s 8-K filing dated January 19, 2024?
The primary purpose of Modular Medical, Inc.'s 8-K filing dated January 19, 2024, is to report a change in its principal executive offices to 10740 Thornmint Road, San Diego, California 92127.
What was the previous business address for Modular Medical, Inc. as listed in the filing?
The previous business address for Modular Medical, Inc. was 16772 West Bernardo Drive, San Diego, CA 92127, as indicated in the 'BUSINESS ADDRESS' section of the filing.
On what date was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on January 19, 2024.
What is the trading symbol and the exchange where Modular Medical, Inc.'s Common Stock is registered?
Modular Medical, Inc.'s Common Stock trades under the symbol MODD and is registered on The Nasdaq Stock Market LLC.
Does this 8-K filing indicate any changes in Modular Medical, Inc.'s financial statements or business operations?
No, this 8-K filing does not indicate any changes in Modular Medical, Inc.'s financial statements or business operations; it is solely an administrative update regarding the company's principal executive office address.
Filing Stats: 580 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2024-01-19 08:30:34
Filing Documents
- ea191833-8k_modular.htm (8-K) — 31KB
- ea191833ex99-1_modular.htm (EX-99.1) — 11KB
- ex99-1_001.jpg (GRAPHIC) — 12KB
- 0001213900-24-004669.txt ( ) — 231KB
- modd-20240119.xsd (EX-101.SCH) — 3KB
- modd-20240119_lab.xml (EX-101.LAB) — 33KB
- modd-20240119_pre.xml (EX-101.PRE) — 22KB
- ea191833-8k_modular_htm.xml (XML) — 3KB
01. Other events
Item 8.01. Other events On January 19, 2024, Modular Medical, Inc. (the "Company") issued a press release (the "Press Release") announcing the premarket submission of the Company's MODD1 next-generation insulin pump to the United States Food and Drug Administration for 510(k) clearance. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Item 8.01 and in Exhibit 99.1 is summary information that is intended to be viewed in the context of the Company's Securities and Exchange Commission ("SEC") filings and other public announcements that the Company may make, by press release or otherwise, from time to time. The Company undertakes no duty or obligation to publicly update or revise the information contained in the Press Release, except as required by law. Any such updating may be made through the filing of other reports or documents with the SEC, through press releases, or through other disclosure. The information provided under this Item 8.01 of this Current Report on Form 8-K, including Exhibit 99.1, is "furnished" and shall not be deemed "filed" with the SEC or incorporated by reference in any filing under the Securities Exchange Act of 1934 or the Securities Act of 1933.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits: Exhibit No. Description 99.1 Press release dated January 19, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. MODULAR MEDICAL, INC. Date: January 19, 2024 By: /s/ James E. Besser James E. Besser Chief Executive Officer 2